Systemic Treatments for Mesothelioma: Standard and Novel

le Kindler, Hedy Lee
Foilsithe 2008

Malignant Pleural Mesothelioma

le Tsao, Anne S., Wistuba, Ignacio, Roth, Jack A., Kindler, Hedy Lee
Foilsithe in J Clin Oncol (2009)

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

le Kindler, Hedy Lee, Wroblewski, Kristen, Wallace, James A., Hall, Michael J., Locker, Gershon, Nattam, Sreenivasa, Agamah, Edem, Stadler, Walter M., Vokes, Everett E.
Foilsithe in Invest New Drugs (2010)

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

le Dubey, Sarita, Jänne, Pasi A., Krug, Lee, Pang, Herbert, Wang, Xiaofei, Heinze, Robin, Watt, Colleen, Crawford, Jeff, Kratzke, Robert, Vokes, Everett, Kindler, Hedy Lee
Foilsithe 2010

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

le Hobday, Timothy J., Qin, Rui, Reidy-Lagunes, Diane, Moore, Malcolm J., Strosberg, Jonathan, Kaubisch, Andreas, Shah, Manisha, Kindler, Hedy Lee, Lenz, Heinz-Josef, Chen, Helen, Erlichman, Charles
Foilsithe in J Clin Oncol (2015)

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

le Kindler, Hedy Lee, Niedzwiecki, Donna, Hollis, Donna, Sutherland, Susan, Schrag, Deborah, Hurwitz, Herbert, Innocenti, Federico, Mulcahy, Mary Frances, O'Reilly, Eileen, Wozniak, Timothy F., Picus, Joel, Bhargava, Pankaj, Mayer, Robert J., Schilsky, Richard L., Goldberg, Richard M.
Foilsithe 2010